ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Syner-Med Pharmaceuticals (Kenya) Limited

Syner-Med Pharmaceuticals (Kenya) Limited is a dissolved company incorporated on 27 October 1995 with the registered office located in London, Greater London. Syner-Med Pharmaceuticals (Kenya) Limited was registered 30 years ago.
Status
Dissolved
Dissolved on 25 February 2025 (8 months ago)
Was 29 years old at the time of dissolution
Via voluntary strike-off
Company No
03119099
Private limited company
Age
30 years
Incorporated 27 October 1995
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 27 October 2024 (1 year ago)
Next confirmation dated 1 January 1970
Last change occurred 7 years ago
Accounts
Not Submitted
Awaiting first accounts
Address
82 St John Street
London
EC1M 4JN
United Kingdom
Address changed on 24 May 2022 (3 years ago)
Previous address was Ds House 306 High Street Croydon CR0 1NG
Telephone
020 86556380
Email
Unreported
People
Officers
3
Shareholders
1
Controllers (PSC)
2
Director • Secretary • British • Lives in UK • Born in May 1960
Director • British • Lives in UK • Born in Oct 1956
Mr Dipak Devji Bhatti
PSC • British • Lives in England • Born in Oct 1956
Virpra Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Syner-Med (Pharmaceutical Products) Limited
Pratima Dipak Bhatti and are mutual people.
Active
Syner-Medica Limited
Pratima Dipak Bhatti and are mutual people.
Active
Virpra Limited
Pratima Dipak Bhatti and are mutual people.
Active
Masai Mara Wilderness Lodge (UK) Limited
Pratima Dipak Bhatti and Dipak Devji Bhatti are mutual people.
Active
Syner-Medica B.V
Pratima Dipak Bhatti and Dipak Devji Bhatti are mutual people.
Active
Syner-Med Pharmaceuticals (Canada) Limited
Pratima Dipak Bhatti and are mutual people.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2014–2023)
Period Ended
31 Aug 2023
For period 31 Aug31 Aug 2023
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£0
Same as previous period
Total Liabilities
-£1.8K
Same as previous period
Net Assets
-£1.8K
Same as previous period
Debt Ratio (%)
Unreported
Latest Activity
Voluntarily Dissolution
8 Months Ago on 25 Feb 2025
Voluntary Gazette Notice
11 Months Ago on 10 Dec 2024
Application To Strike Off
11 Months Ago on 3 Dec 2024
Confirmation Submitted
1 Year Ago on 8 Nov 2024
Micro Accounts Submitted
1 Year 5 Months Ago on 31 May 2024
Confirmation Submitted
1 Year 11 Months Ago on 5 Dec 2023
Dormant Accounts Submitted
2 Years 5 Months Ago on 5 Jun 2023
Confirmation Submitted
3 Years Ago on 27 Oct 2022
Registered Address Changed
3 Years Ago on 24 May 2022
Virpra Limited (PSC) Appointed
9 Years Ago on 6 Apr 2016
Get Credit Report
Discover Syner-Med Pharmaceuticals (Kenya) Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Final Gazette dissolved via voluntary strike-off
Submitted on 25 Feb 2025
First Gazette notice for voluntary strike-off
Submitted on 10 Dec 2024
Application to strike the company off the register
Submitted on 3 Dec 2024
Confirmation statement made on 27 October 2024 with no updates
Submitted on 8 Nov 2024
Micro company accounts made up to 31 August 2023
Submitted on 31 May 2024
Confirmation statement made on 27 October 2023 with no updates
Submitted on 5 Dec 2023
Accounts for a dormant company made up to 31 August 2022
Submitted on 5 Jun 2023
Confirmation statement made on 27 October 2022 with no updates
Submitted on 27 Oct 2022
Notification of Virpra Limited as a person with significant control on 6 April 2016
Submitted on 27 Oct 2022
Registered office address changed from Ds House 306 High Street Croydon CR0 1NG to 82 st John Street London EC1M 4JN on 24 May 2022
Submitted on 24 May 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year